cerrar
Tagged with A

Jay Dong – General Manager (China and APAC) & Vice…
Jay Dong, founding GM (China and APAC) and Global VP of Cell Signaling Technology, shares the company’s success in the past ten years; the economic…

Orphan Drug Accessibility & Social Medical Coverage in China
Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare disease patient himself, he is…

Rethinking Clinical Trials in Rare Diseases
Drug development in rare diseases is currently in a very exciting time. While much of the focus is on the scientific advances,  access to rare…

The Ideal Pharma Country Manager: China (Cornerstone…
What do executive recruitment firms look for when hiring country managers for multinational pharma companies in some of the world’s most challenging…

Silvia Casellas – CEO, Anagram, Spain
Silvia Casellas, CEO of Anagram, a Spanish CRO, discusses the challenges of the consolidation process the company has gone in recent years, the…

MENA Pharma Market Set to Grow to USD 60 Billion
The Middle East and North Africa (MENA) region’s pharmaceutical market is projected to reach a value of around USD 60 billion by 2025 according to…

Lingshi Tan – Founder, Chairman and CEO, dMed, China
Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech innovation and how it motivated him to…

India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India's ambitious healthcare insurance scheme,…

Teresa Chavarria Gimenez – Director General of Planning,…
Teresa Chavarria Gimenez, director general of planning, research and training at the Ministry of Health of the Community of Madrid, highlights her…

John Gong – CEO, 3D Medicines, China
Dr John Gong, CEO of 3D Medicines, shares the company’s ‘3D – diagnostics, data, and drug development’ approach to cancer precision medicine;…

Jeewoong Son – President, LG Life Sciences, South Korea
LG Life Sciences is one the early pioneers of innovative drug development in Korea with a diversified portfolio of chemical drugs, vaccines,…

Rafael Mella – General Manager, Nordic Pharma Spain and…
Rafael Mella, general manager of Nordic Pharma Spain & Portugal, highlights the steps he has taken to set-up the foundations for the company in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here